Mid-Morning Look: June 05, 2023

Auto PostDaily Market Report

Mid-Morning Look

Monday, June 05, 2023






DJ Industrials




S&P 500








Russell 2000






U.S. stocks opened higher, continuing their torrid advance with the S&P 500 rising as much as 20% now from the October lows, setting to enter Bull market territory, led by a new record high for tech bellwether Apple (AAPL) ahead of its annual WWDC keynote presentation later today at 1:00 PM ET. The S&P 500 index failed just shy of the 4,300 level this morning after rising again last week and the Nasdaq comes into the trading week up 6-straght weeks. Treasury yields tumbled after mixed economic data (weaker ISM Services data and Factory Orders, but also slowing inflation data points in prices paid). Global markets also rip-roaring as Japan’s NIKKEI hits 32,000 a 33-year high. Smallcaps (IWM) no follow through from Fridays outperformance, been sliding since the open now the 200d below at $179.80 (broke above on Friday) after rising 4.6% the last 2-days. Energy stocks and oil prices move higher initially after Saudi Arabia unveiled an extra 1 million barrel-a-day oil supply cut in July at its OPEC+ meeting this weekend to support the market, but prices have pulled back since the open. Financials a drag early after the WSJ reported large US lenders may face a 20% increase in capital requirements in the aftermath of the collapse of regional banks. Morgan Stanley bearish strategist Mike Wilson said today “we still expect a meaningful earnings recession this year…we lower our base case 2023 earnings forecast from US$195 to US$185 (17% below consensus) but have not changed our base case S&P 500 target for end-2023, which remains 3,900.” Markets again stabilized by strength in large cap tech with AAPL, AMZN, GOOGL, NFLX, AMD, MSFT, META trading higher early (helping S&P and Nasdaq). 


Economic Data

·     ISM non-manufacturing for May 50.3 vs. 51.9 in April and est. 52.2; business activity index 51.5 in May vs 52.0 in April; prices paid index 56.2 in May vs 59.6 in April; non-manufacturing new orders index 52.9 in May vs 56.1 in April; employment index 49.2 in May vs 50.8 in April.

·     April factory orders rose +0.4% vs. est. +0.8% and vs March +0.6%; April factory orders ex-transportation -0.2% vs March -1.0%; factory orders ex-defense -0.4% vs March +0.5%.

·     May S&P Global Composite PMI reported at 54.3 vs. est. 54.5 and prior 53.4; May S&P Global Services PMI at 54.9 vs. est. 55.1 and prior 53.6.







WTI Crude















10-Year Note






·     AAPL +1%; trades new all-time highs, topping $183 ahead of annual WWDC keynote presentation later today at 1:00 PM ET.

·     AMED +14%; said received an unsolicited proposal from Optum to acquire all the outstanding shares of its common stock in an all-cash transaction for $100 per share and believes could be considered “superior” to the buyout deal already agreed on with OPCH in early May https://tinyurl.com/3xz77abe

·     CIR +49%; after KKR agreed to acquire the company for $1.6B, including the assumption of debt, paying CIR shareholders $49 per share or 55% premium to Friday. https://tinyurl.com/2vvj6ykp

·     DAWN +12%; as reported positive data from registrational mid-stage trial for its investigational monotherapy Tovorafenib for a type of brain tumor, as data shows overall response rate of 67% and clinical benefit rate of 93% in 69 patients.

·     FHTX +10%; after saying the FDA late last week lifted clinical hold on early-stage dose escalation study of blood cancer drug FHD-286; health regulator last year had placed a full clinical hold on the trial, months after a partial hold due to one death.

·     IMGN +6%; said its experimental ovarian cancer therapy when compared to chemotherapy showed 35% reduction in the risk of death or length of time the disease does not get worse during and after the treatment in a late-stage study.

·     PANW +4%; to replace DISH in S&P 500 at open on 6/20

·     XEL +2%; among top movers in the S&P as utility stocks among sector leaders.



·     BLPH -84%; said its phase 3 rebuild study of INOpulse to treat fibrotic interstitial lung disease failed to meet its primary endpoint.

·     EL -2%; downgraded from Outperform to Perform at Oppenheimer saying based on its work, it now sees a less favorable risk/reward scenario.

·     EPAM -14%; after lowered its Q2 and 2023 profit and sales outlook due to a further deterioration in the near-term demand environment.

·     MNK -22%; after Friday night’s WSJ article reporting that the drugmaker is considering once again filing for bankruptcy.

·     NET -3%; after UBS initiates with a Sell Rating and Price Target of $55 following the 70% rally in May, saying investors are pricing in too much near-term AI benefit.

·     RCUS -7%; after mid stage study w GILD showed declined benefit in reducing disease progression in the treatment of a type of lung cancer, as per new interim data.


Market commentary provided by Hammerstone Markets, Inc, a firm separate from and not affiliated with Regal Securities. Regal Securities has not participated in the creation of the content, and does not explicitly or implicitly endorse the content.

Live Trading

Open an Account

Paper Trading